Literature DB >> 10590100

Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

S D Lawn1, B D Roberts, G E Griffin, T M Folks, S T Butera.   

Abstract

Antigens derived from host cells are detectable in the envelope of human immunodeficiency virus type 1 (HIV-1) and result in a distinctive viral phenotype reflecting that of the host cell. An immunomagnetic capture assay targeting discriminatory host proteins was developed to differentiate between HIV-1 derived from macrophages and lymphocytes. HIV-1 propagated in macrophages or lymphocytes in vitro was selectively captured by monoclonal antibodies directed against the virally incorporated cell-type-specific host markers CD36 (macrophages) and CD26 (lymphocytes). Furthermore, by targeting these markers, virus of defined cellular origin was selectively captured from a mixed pool of in vitro-propagated viruses. This technique was further refined in order to determine the impact of opportunistic infection on HIV-1 expression from these cellular compartments in vivo. Analysis of cell-free virus purified from plasma of patients with HIV-1 infection suggested that in those with an opportunistic infection, viral replication occurred in activated lymphocytes. Interestingly, there was also significant replication in activated macrophages in those patients with untreated pulmonary tuberculosis. Thus, in addition to lymphocytes, the macrophage cellular pool may serve as an important source of cell-free HIV-1 in patients with opportunistic infections that lead to marked macrophage activation. This novel viral capture technique may allow researchers to address a wide range of important questions regarding virus-host dynamics.

Entities:  

Mesh:

Year:  2000        PMID: 10590100      PMCID: PMC111522     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  The ratio of defective HIV-1 particles to replication-competent infectious virions.

Authors:  A S Bourinbaiar
Journal:  Acta Virol       Date:  1994-02       Impact factor: 1.162

Review 2.  The acquisition of host-encoded proteins by nascent HIV-1.

Authors:  M J Tremblay; J F Fortin; R Cantin
Journal:  Immunol Today       Date:  1998-08

3.  Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.

Authors:  N N Tandon; U Kralisz; G A Jamieson
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

4.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.

Authors:  I Stamenkovic; M Amiot; J M Pesando; B Seed
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

5.  Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.

Authors:  B Hofmann; P Nishanian; J L Fahey; I Esmail; A L Jackson; R Detels; W Cumberland
Journal:  Clin Immunol Immunopathol       Date:  1991-11

6.  The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75).

Authors:  C Scheibenbogen; U Keilholz; M Richter; R Andreesen; W Hunstein
Journal:  Res Immunol       Date:  1992-01

7.  Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.

Authors:  M Saifuddin; T Hedayati; J P Atkinson; M H Holguin; C J Parker; G T Spear
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

8.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Authors:  L O Arthur; J W Bess; R C Sowder; R E Benveniste; D L Mann; J C Chermann; L E Henderson
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

Authors:  R J Orentas; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

10.  Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.

Authors:  D C Montefiori; R J Cornell; J Y Zhou; J T Zhou; V M Hirsch; P R Johnson
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

View more
  29 in total

1.  Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.

Authors:  S D Lawn; S T Butera
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

3.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

5.  Flow virometric sorting and analysis of HIV quasispecies from plasma.

Authors:  Thomas Musich; Jennifer C Jones; Brandon F Keele; Lisa M Miller Jenkins; Thorsten Demberg; Thomas S Uldrick; Robert Yarchoan; Marjorie Robert-Guroff
Journal:  JCI Insight       Date:  2017-02-23

6.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 8.  HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.

Authors:  Paul R Gorry; Nicholas Francella; Sharon R Lewin; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2013-10-24       Impact factor: 4.962

9.  Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART.

Authors:  Carlos A Lopez; Manuel Vazquez; Martin D Hill; Maria Del C Colon; Tirtsa Porrata-Doria; Ian C D Johnston; Eric Lorenzo
Journal:  Arch Virol       Date:  2010-04-23       Impact factor: 2.574

10.  The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.

Authors:  Corinne Barat; Geneviève Martin; Adrien R Beaudoin; Jean Sévigny; Michel J Tremblay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.